136 related articles for article (PubMed ID: 3441501)
1. Localization of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues.
Aizawa K; Okunaka T; Ohtani T; Kawabe H; Yasunaka Y; O'Hata S; Ohtomo N; Nishimiya K; Konaka C; Kato H
Photochem Photobiol; 1987 Nov; 46(5):789-93. PubMed ID: 3441501
[No Abstract] [Full Text] [Related]
2. Lipoprotein-mediated distribution of N-aspartyl chlorin-E6 in the mouse.
Kessel D; Whitcomb KL; Schulz V
Photochem Photobiol; 1992 Jul; 56(1):51-6. PubMed ID: 1508982
[TBL] [Abstract][Full Text] [Related]
3. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Ferrario A; Kessel D; Gomer CJ
Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
[TBL] [Abstract][Full Text] [Related]
5. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.
Nelson JS; Roberts WG; Berns MW
Cancer Res; 1987 Sep; 47(17):4681-5. PubMed ID: 2957047
[TBL] [Abstract][Full Text] [Related]
6. In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-aspartyl chlorin e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II.
Roberts WG; Berns MW
Lasers Surg Med; 1989; 9(2):90-101. PubMed ID: 2523995
[TBL] [Abstract][Full Text] [Related]
7. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
[TBL] [Abstract][Full Text] [Related]
8. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
Spikes JD; Bommer JC
J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Gomer CJ; Ferrario A
Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic activity of chlorin e6 and chlorin e6 ethylenediamide in vitro and in vivo.
Gurinovich GP; Zorina TE; Melnov SB; Melnova NI; Gurinovich IF; Grubina LA; Sarzhevskaya MV; Cherenkevich SN
J Photochem Photobiol B; 1992 Apr; 13(1):51-7. PubMed ID: 1403368
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
[TBL] [Abstract][Full Text] [Related]
12. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
14. Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors.
Kostenich GA; Zhuravkin IN; Zhavrid EA
J Photochem Photobiol B; 1994 Mar; 22(3):211-7. PubMed ID: 8014753
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic effect using a diode laser with mono-l-aspartyl chlorin e6 (NPe6) for implanted mouse tumor.
Katsumi T; Kato H; Okunaka T; Kuroiwa Y; Yoshiteru I; Saito K; Konaka C; Aizawa K
J Clin Laser Med Surg; 1994 Aug; 12(4):211-3. PubMed ID: 10147480
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H
Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472
[TBL] [Abstract][Full Text] [Related]
17. Talaporfin: LS 11, LS11, ME 2906, mono-L-aspartyl chlorin e6, NP e6, NPE 6, taporfin sodium.
Drugs R D; 2003; 4(1):69-71. PubMed ID: 12568643
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice.
Shi H; Liu Q; Qin X; Wang P; Wang X
Biopharm Drug Dispos; 2011 Sep; 32(6):319-32. PubMed ID: 21815170
[TBL] [Abstract][Full Text] [Related]
19. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Peng Q; Moan J; Ma LW; Nesland JM
Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]